139 related articles for article (PubMed ID: 9919332)
1. Uterine papillary serous carcinoma--the KK Hospital experience.
Ho TH; Lim TL; Tan HS
Ann Acad Med Singap; 1998 Sep; 27(5):640-4. PubMed ID: 9919332
[TBL] [Abstract][Full Text] [Related]
2. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.
Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235
[TBL] [Abstract][Full Text] [Related]
3. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival in uterine clear cell carcinoma and uterine papillary serous carcinoma.
Lindahl B; Persson J; Ranstam J; Willén R
Anticancer Res; 2010 Sep; 30(9):3727-30. PubMed ID: 20944161
[TBL] [Abstract][Full Text] [Related]
5. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary?
Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227
[TBL] [Abstract][Full Text] [Related]
6. Uterine papillary serous carcinoma: a review.
Gehrig PA
Expert Opin Pharmacother; 2007 Apr; 8(6):809-16. PubMed ID: 17425476
[TBL] [Abstract][Full Text] [Related]
7. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
[TBL] [Abstract][Full Text] [Related]
8. Uterine papillary serous carcinoma: patterns of failure and survival.
Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
[TBL] [Abstract][Full Text] [Related]
9. Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma.
Bancher-Todesca D; Neunteufel W; Williams KE; Prainsack D; Breitenecker G; Friedlander ML; Hacker NF
Gynecol Oncol; 1998 Dec; 71(3):344-7. PubMed ID: 9887228
[TBL] [Abstract][Full Text] [Related]
10. Analysis of clinical and pathological characteristics, treatment methods, survival, and prognosis of uterine papillary serous carcinoma.
Solmaz U; Ekin A; Mat E; Gezer C; Dogan A; Biler A; Peker N; Hasdemir PS; Sanci M
Tumori; 2016 Dec; 102(6):593-599. PubMed ID: 27514313
[TBL] [Abstract][Full Text] [Related]
11. Uterine papillary serous carcinoma (pure and mixed type) compared with moderately and poorly differentiated endometrioid carcinoma. A clinicopathologic study.
Halperin R; Zehavi S; Langer R; Hadas E; Bukovsky I; Schneider D
Eur J Gynaecol Oncol; 2002; 23(4):300-4. PubMed ID: 12214728
[TBL] [Abstract][Full Text] [Related]
12. Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.
Hong JC; Foote J; Broadwater G; Gaillard S; Havrilesky LJ; Chino JP
Int J Gynecol Cancer; 2017 May; 27(4):720-729. PubMed ID: 28375927
[TBL] [Abstract][Full Text] [Related]
13. Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study.
Gadducci A; Cosio S; Landoni F; Maggino T; Zola P; Fuso L; Sartori E
Int J Gynecol Cancer; 2012 Oct; 22(8):1355-60. PubMed ID: 22976496
[TBL] [Abstract][Full Text] [Related]
14. Uterine papillary serous carcinoma: study of 19 cases.
Piura B; Meirovitz M; Shmulman M; Yanai-Inbar I; Cohen Y; Dgani R
Eur J Obstet Gynecol Reprod Biol; 1998 Jul; 79(1):69-73. PubMed ID: 9643407
[TBL] [Abstract][Full Text] [Related]
15. Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy.
Leath CA; Numnum TM; Kendrick JE; Frederick PJ; Rocconi RP; Conner MG; Straughn JM
Int J Gynecol Cancer; 2009 Jul; 19(5):888-91. PubMed ID: 19574779
[TBL] [Abstract][Full Text] [Related]
16. What staging surgery should be performed on patients with uterine papillary serous carcinoma?
Geisler JP; Geisler HE; Melton ME; Wiemann MC
Gynecol Oncol; 1999 Sep; 74(3):465-7. PubMed ID: 10479511
[TBL] [Abstract][Full Text] [Related]
17. Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer.
Townamchai K; Berkowitz R; Bhagwat M; Damato AL; Friesen S; Lee LJ; Matulonis U; O'Farrell D; Viswanathan AN
Gynecol Oncol; 2013 Apr; 129(1):18-21. PubMed ID: 23262378
[TBL] [Abstract][Full Text] [Related]
18. FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival.
Memarzadeh S; Holschneider CH; Bristow RE; Jones NL; Fu YS; Karlan BY; Berek JS; Farias-Eisner R
Int J Gynecol Cancer; 2002; 12(5):454-8. PubMed ID: 12366662
[TBL] [Abstract][Full Text] [Related]
19. Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy.
Huh WK; Powell M; Leath CA; Straughn JM; Cohn DE; Gold MA; Falkner CA; Carey DE; Herzog T; Fowler JM; Partridge EE; Kilgore LC; Alvarez RD
Gynecol Oncol; 2003 Dec; 91(3):470-5. PubMed ID: 14675664
[TBL] [Abstract][Full Text] [Related]
20. Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?
Kwon JS; Abrams J; Sugimoto A; Carey MS
Int J Gynecol Cancer; 2008; 18(4):820-4. PubMed ID: 17892450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
